The global water bottling market grows annually. Today, to ensure consumer safety, it is important to verify the possible migration of compounds from bottles into the water contained in them. Potential health risks due to the prevalence of bisphenol A (BPA) and phthalates (PAEs) exposure through water bottle consumption have become an important issue. BPA, benzyl butyl phthalate (BBP), di-n-butyl phthalate (DBP) and di (2-ethylhexyl) phthalate (DEHP) can cause adverse effects on human health. Papers of literature published in English, with BPA, BBP, DBP and DEHP detections during 2017, by 2019 by liquid chromatography and gas chromatography analysis methods were searched. The highest concentrations of BPA, BBP, DBP and DEHP in all the bottled waters studied were found to be 5.7, 12.11, 82.8 and 64.0 μg/L, respectively. DBP was the most compound detected and the main contributor by bottled water consumption with 23.7% of the Tolerable Daily Intake (TDI). Based on the risk assessment, BPA, BBP, DBP and DEHP in commercial water bottles do not pose a serious concern for humans. The average estrogen equivalent level revealed that BPA, BBP, DBP and DEHP in bottled waters may induce adverse estrogenic effects on human health.

全球瓶装水市场每年都在增长。今天，为了确保消费者的安全，验证化合物从瓶子中迁移到其中所含水中的可能性非常重要。由于饮用瓶装水时双酚 A (BPA) 和邻苯二甲酸酯 (PAE) 暴露的普遍存在，潜在的健康风险已成为一个重要问题。BPA, 邻苯二甲酸苄丁酯 (BBP), di- n邻苯二甲酸丁酯 (DBP) 和邻苯二甲酸二 (2-乙基己基) 酯 (DEHP) 会对人体健康造成不利影响。检索2017年至2019年采用液相色谱和气相色谱分析方法检测BPA、BBP、DBP和DEHP的英文文献。在所研究的所有瓶装水中，BPA、BBP、DBP 和 DEHP 的最高浓度分别为 5.7、12.11、82.8 和 64.0 μg/L。DBP 是检测到的最多的化合物，也是瓶装水消耗量的主要贡献者，占每日可耐受摄入量 (TDI) 的 23.7%。根据风险评估，商业水瓶中的 BPA、BBP、DBP 和 DEHP 不会对人类造成严重关注。平均雌激素当量水平显示，瓶装水中的 BPA、BBP、DBP 和 DEHP 可能会对人体健康产生不利的雌激素影响。